Angle (AGL)


Latest News

ANGLE losses widen

ANGLE's loss for the year ended 30 April rose to 6.4m - up from 5.1m last time. AMGLE said this reflected planned investm...

Preliminary Results

Announcement of full year/4th quarter financial results

Preclinical Study Presented At Tumor Boston Summit

Notice of Results

Notification of the date financial results will be published

All News

27-07-17ANGLE losses widen StockMarketWire
27-07-17Preliminary ResultsRNS
20-07-17Preclinical Study Presented At Tumor Boston SummitRNS
06-07-17Notice of ResultsRNS
04-07-17ANGLE confirms successful data in cancer studies StockMarketWire
04-07-17Successful Headline Data in Ovarian Cancer StudiesRNS
15-06-17FTSE lower amid ex-divs ahead of BoE rate callStockMarketWire
15-06-17Parsortix breakthrough in prostate cancerRNS
05-06-17Parsortix success reported at ASCO, says ANGLE StockMarketWire
05-06-17Success with Parsortix in Colorectal CancerRNS
03-05-17Business UpdateRNS
04-04-17Holding(s) in CompanyRNS
03-04-17Parsortix enables analysis in head and neck cancerRNS
30-03-17Prostate Cancer UpdateRNS
13-02-17Selected for European Cancer ID ProgrammeRNS
26-01-17Interim Evaluation of Ovarian Cancer StudyRNS
26-01-17Interim ResultsRNS
06-01-17ANGLE Plc to present at the Growth and Innovation Forum 2017 in London on 31 January 2017StockMarketWire
04-01-17ANGLE schedules interims StockMarketWire
04-01-17Notice of ResultsRNS
29-12-16Our AIM tip soars 60% in 2016 Interactive Investor
24-11-16Result of GMRNS
04-11-16ANGLE welcomes new research supporting Parsortix StockMarketWire
04-11-16Barts Research Supports Potential Use of ParsortixRNS
01-11-16Notice of GMRNS
27-10-16Director's share purchaseRNS
07-10-16Holding(s) in CompanyRNS
04-10-16Result of AGMRNS
30-09-16ANGLE notes research results in Clinical ChemistryStockMarketWire
30-09-16Research published in Clinical ChemistryRNS
19-09-16Issue of EquityRNS
09-09-16Annual Report and Accounts and Notice of AGMRNS
04-08-16MD Anderson Cancer Center poster presentationRNS
02-08-16Edison issues ADR update on AngleRNS
28-07-16ANGLE revenue upStockMarketWire
28-07-16Use of Parsortix in GANNET53 drug trialRNS
28-07-16Preliminary ResultsRNS
27-07-16ANGLE initiates ovarian cancer study in the USStockMarketWire
27-07-16Initiation of 200 patient US ovarian cancer studyRNS

RSS feeds

  • Editorial news feed for LSE:AGL Editorial
  • Regulatory news feed for LSE:AGL Regulatory